Combinatorial development of nebulized mRNA delivery formulations for the lungs

Jan 1, 2023·

J. Witten

,

A. Jiang

,

I. Raji

,

F. Eweje

,

C. MacIsaac

,

F. Oladimeji

,

R. Langer

,

D. Anderson

· 0 min read

Abstract

Combinatorial screening approach to develop nebulized mRNA delivery formulations for the lungs.

Type

Journal article

Publication

Nature Nanotechnology

Last updated on Jan 1, 2023

Lipid Nanoparticles Gene Therapy Nebulization

← A comparison of the physicochemical properties of native mucus and reconstituted mucin gels Feb 1, 2023

Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA Jan 1, 2023 →